133 related articles for article (PubMed ID: 23813768)
1. Risk of emergent bradycardia associated with initiation of immediate- or slow-release metoprolol.
Shin J; Gonzales M; Pletcher MJ
Pharmacotherapy; 2013 Dec; 33(12):1353-61. PubMed ID: 23813768
[TBL] [Abstract][Full Text] [Related]
2. Risk of emergent bradycardia associated with the use of carvedilol and metoprolol in routine clinical practice.
Shin J; Pletcher MJ
Am J Med; 2013 Sep; 126(9):805-810.e5. PubMed ID: 23968902
[TBL] [Abstract][Full Text] [Related]
3. Importance of beta-blocker dose in prevention of ventricular tachyarrhythmias, heart failure hospitalizations, and death in primary prevention implantable cardioverter-defibrillator recipients: a Danish nationwide cohort study.
Ruwald AC; Gislason GH; Vinther M; Johansen JB; Nielsen JC; Philbert BT; Torp-Pedersen C; Riahi S; Jøns C
Europace; 2018 Sep; 20(FI2):f217-f224. PubMed ID: 29684191
[TBL] [Abstract][Full Text] [Related]
4. Combining Antidepressants with β-Blockers: Evidence of a Clinically Significant CYP2D6 Drug Interaction.
Shin J; Hills NK; Finley PR
Pharmacotherapy; 2020 Jun; 40(6):507-516. PubMed ID: 32342526
[TBL] [Abstract][Full Text] [Related]
5. Effect of metoprolol versus carvedilol on outcomes in MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy).
Ruwald MH; Ruwald AC; Jons C; Alexis J; McNitt S; Zareba W; Moss AJ
J Am Coll Cardiol; 2013 Apr; 61(14):1518-26. PubMed ID: 23500269
[TBL] [Abstract][Full Text] [Related]
6. Valsartan versus lisinopril or extended-release metoprolol in preventing cardiovascular and renal events in patients with hypertension.
Delea TE; Taneja C; Moynahan A; Thomas SK; Frech-Tamas F; Oster G
Am J Health Syst Pharm; 2007 Jun; 64(11):1187-96. PubMed ID: 17519461
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort.
Tang CH; Wang CC; Chen TH; Hong CY; Sue YM
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26738790
[TBL] [Abstract][Full Text] [Related]
8. Persistence with nebivolol in the treatment of hypertension: a retrospective claims analysis.
Signorovitch JE; Samuelson TM; Ramakrishnan K; Marynchenko M; Wu EQ; Blum SI; Ramasamy A; Chen S
Curr Med Res Opin; 2012 Apr; 28(4):591-9. PubMed ID: 22352883
[TBL] [Abstract][Full Text] [Related]
9. Kidney function and population-based outcomes of initiating oral atenolol versus metoprolol tartrate in older adults.
Fleet JL; Weir MA; McArthur E; Ozair S; Devereaux PJ; Roberts MA; Jain AK; Garg AX
Am J Kidney Dis; 2014 Dec; 64(6):883-91. PubMed ID: 25037562
[TBL] [Abstract][Full Text] [Related]
10. Severe sinus bradycardia after initiation of bupropion therapy: a probable drug-drug interaction with metoprolol.
McCollum DL; Greene JL; McGuire DK
Cardiovasc Drugs Ther; 2004 Jul; 18(4):329-30. PubMed ID: 15367832
[TBL] [Abstract][Full Text] [Related]
11. Impact of a Metoprolol Extended Release Shortage on Post-Myocardial Infarction β-Blocker Utilization, Adherence, and Rehospitalization.
Bykov K; Gagne JJ; Wang B; Choudhry NK
Circ Cardiovasc Qual Outcomes; 2018 Oct; 11(10):e004096. PubMed ID: 30354573
[TBL] [Abstract][Full Text] [Related]
12. A metoprolol-terbinafine combination induced bradycardia.
Bebawi E; Jouni SS; Tessier AA; Frenette AJ; Brindamour D; Doré M
Eur J Drug Metab Pharmacokinet; 2015 Sep; 40(3):295-9. PubMed ID: 24894748
[TBL] [Abstract][Full Text] [Related]
13. Similar risk reduction of death of extended-release metoprolol once daily and immediate-release metoprolol twice daily during 5 years after myocardial infarction.
Herlitz J; Dellborg M; Karlson BW; Lindqvist J; Sandèn W; Svensson H; Sjölin M; Wedel H
Cardiovasc Drugs Ther; 1999 Apr; 13(2):127-35. PubMed ID: 10372228
[TBL] [Abstract][Full Text] [Related]
14. A pharmacokinetic and pharmacodynamic comparison of immediate-release metoprolol and extended-release metoprolol CR/XL in patients with suspected acute myocardial infarction: a randomized, open-label study.
Karlson BW; Dellborg M; Gullestad L; Aberg J; Sugg J; Herlitz J
Cardiology; 2014; 127(2):73-82. PubMed ID: 24247812
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of metoprolol metabolism and potentiation of its effects by paroxetine in routinely treated patients with acute myocardial infarction (AMI).
Goryachkina K; Burbello A; Boldueva S; Babak S; Bergman U; Bertilsson L
Eur J Clin Pharmacol; 2008 Mar; 64(3):275-82. PubMed ID: 18043911
[TBL] [Abstract][Full Text] [Related]
16. [Bradycardia after beginning therapy with metoprolol and paroxetine].
König F; Häfele M; Hauger B; Löble M; Wössner S; Wolfersdorf M
Psychiatr Prax; 1996 Sep; 23(5):244-5. PubMed ID: 8992519
[TBL] [Abstract][Full Text] [Related]
17. Carvedilol versus controlled-release metoprolol for elderly veterans with heart failure.
Rector TS; Anand IS; Nelson DB; Ensrud KE
J Am Geriatr Soc; 2008 Jun; 56(6):1021-7. PubMed ID: 18384583
[TBL] [Abstract][Full Text] [Related]
18. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.
Hjalmarson A; Goldstein S; Fagerberg B; Wedel H; Waagstein F; Kjekshus J; Wikstrand J; El Allaf D; Vítovec J; Aldershvile J; Halinen M; Dietz R; Neuhaus KL; Jánosi A; Thorgeirsson G; Dunselman PH; Gullestad L; Kuch J; Herlitz J; Rickenbacher P; Ball S; Gottlieb S; Deedwania P
JAMA; 2000 Mar; 283(10):1295-302. PubMed ID: 10714728
[TBL] [Abstract][Full Text] [Related]
19. Hospitalization rates of generic metoprolol compared with the original beta-blocker in an epidemiological database study.
Ahrens W; Hagemeier C; Mühlbauer B; Pigeot I; Püntmann I; Reineke A; Steinbach M; Timm J
Pharmacoepidemiol Drug Saf; 2007 Dec; 16(12):1298-307. PubMed ID: 17957709
[TBL] [Abstract][Full Text] [Related]
20. beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failure.
Terra SG; Pauly DF; Lee CR; Patterson JH; Adams KF; Schofield RS; Belgado BS; Hamilton KK; Aranda JM; Hill JA; Yarandi HN; Walker JR; Phillips MS; Gelfand CA; Johnson JA
Clin Pharmacol Ther; 2005 Mar; 77(3):127-37. PubMed ID: 15735607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
